Starling Oncology, Inc. (STLN)
NASDAQ: STLN · Real-Time Price · USD
6.13
-0.34 (-5.26%)
At close: Aug 24, 2026, 4:00 PM EDT
6.14
+0.01 (0.16%)
After-hours: Aug 24, 2026, 7:30 PM EDT
Starling Oncology Market Cap
Starling Oncology has a market cap or net worth of $624.75 million as of August 24, 2026. Its market cap has increased by 76.29% in one year.
Market Cap
624.75M
Enterprise Value
688.44M
1-Year Change
76.29%
Ranking
Category
Stock Price
$6.13
ChartMarket Cap Chart
Since July 23, 2021, Starling Oncology's market cap has increased from $990.00 to $624.75M, an increase of 63,105,534.85%. That is a compound annual growth rate of 1,278.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 24, 2026 | 624.75M | 78.38% |
| Dec 31, 2025 | 350.24M | 1,400.09% |
| Dec 31, 2024 | 23.35M | -84.48% |
| Dec 29, 2023 | 150.45M | 22.52% |
| Dec 30, 2022 | 122.80M | -82.81% |
| Dec 31, 2021 | 714.18M | 72,139,108.08% |
| Jul 23, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ardent Health | 1.55B |
| InnovAge Holding | 1.49B |
| The Pennant Group | 1.36B |
| AMN Healthcare Services | 1.33B |
| Nutex Health | 1.27B |
| U.S. Physical Therapy | 1.17B |
| GMR Solutions | 1.05B |
| Strata Critical Medical | 552.03M |